IMNN (Imunon, Inc.) Total Business Assets

Official company branding of imunon.com (IMNN)

Imunon, Inc. (IMNN) brings together leading specialists in genetics and oncology, attracting talent with a cutting-edge foundation for immunotherapeutic research. The company's development of anti-cancer drugs is not subject to market cycles or seasonality, demonstrating resilience to crises. Growth is supported by the success of plasmid platform tests, while cash reserves stand at 11.90. This chart of the company's total asset quotes is provided below.

IMNN - Imunon Company Total Assets over the range 04/28/2023 - 10/30/2026

Analytical breakdowns and data insights for company imunon.com (IMNN)

- stock quotes and analyst forecast:
Share Price Imunon|IMNN - Analyst Consensus Forecast
- business market valuation indicators:
Market Capitalization IMNN|IMNN - Total Company Value
- book capitalization information:
Equity per Share Imunon|IMNN - Book Capitalization|Market Capitalization to Book Value Ratio imunon.com|IMNN - Company Total Assets
- debt and liquidity details:
Total Debt to Capital Coefficient Imunon, Inc.|IMNN - Long-Term Debt to Equity|Short-Term Debt to Equity Ratio Imunon|IMNN - Company Total Debt|Debts to Book Capitalization IMNN|IMNN - Company Long-Term Debt|Company Short-Term Indebtedness Imunon|Immediate Liquidity imunon.com
- earnings and market ratios statistics:
IMNN - Company Net Income
Summary company analysis:Imunon, Inc.
Mass-produced product of Imunon Inc

For Imunon, Inc. (IMNN), the growth of all company resources reflects the efficiency of capital management given the total reliance on external contract research and manufacturing organizations (CRO/CMO). This metric, calculated inversely via ROA, measures the total volume of controlled assets, allowing investors to assess the financial stability of a biotech startup lacking its own facilities and the risks of liquidity freezes at extreme metric values.

Main competitors

Total Business Assets TEM|QGEN (Qiagen) - Company Total Assets|Total Business Assets IONS (Ionis Pharmaceuticals, Inc.)|Aggregate Company Assets Repligen Corp. (RGEN)|Avidity Corp - Total Business Assets|Company Total Assets CRSP (CRISPR Therapeutics AG)|Company Total Assets genedx.com WGS|Ultragenyx - Company Total Assets|Company Total Asset Base Beam Therapeutics Inc BEAM|Sarepta Therapeutics Inc (SRPT) - Aggregate Company Assets|Cumulative Company Assets Twist Bioscience Corp|Cumulative Company Assets TXG|Company Total Assets intelliatx.com|Aggregate Company Assets Stoke Therapeutics, Inc. (STOK)|BioLife Solutions Inc - Total Business Assets|Aggregate Company Assets Wave Life Sciences Corp WVE|Maze Therapeutics Corp (MAZE) - Company Assets|SION - Aggregate Company Assets|PRME (primemedicine.com) - Total Business Assets|TSHA (Taysha Gene Therapies, Inc.) - Cumulative Company Assets|uniQure NV - Aggregate Asset Value|MGTX (MeiraGTx PLC) - Company Total Assets|REGENXBIO Corp (RGNX) - Company Total Asset Base|Aggregate Company Assets Solid Biosciences Inc. (SLDB)|ocugen.com - Total Business Assets|Company Total Assets PACB (PacBio)|BNTC - Cumulative Company Assets|DSGN: Cumulative Company Assets|Company Total Asset Base Rocket Corp RCKT|FDMT: Company Total Assets|LXEO - Company Total Asset Base|Aggregate Company Assets Korro Bio Inc.|Cumulative Company Assets Editas Medicine Inc (EDIT)|Aggregate Company Assets Silence Therapeutics Inc. (SLN)|proqr.com - Total Business Assets|Aggregate Company Assets Codexis CDXS|SGMO: Total Business Assets|Nautilus Biotechnology Inc - Company Total Assets|MGX (Metagenomi Inc.) - Total Business Assets|Precision BioSciences, Inc. (DTIL) - Aggregate Company Assets|Total Business Assets GBIO|BOLD (Boundless Bio, Inc.) - Company Total Assets|Company Total Assets Exicure Corp|Company Total Assets PHIO|Company Total Asset Base mustangbio.com|Aggregate Company Assets TransCode Therapeutics, Inc. RNAZ|BNGO - Cumulative Company Assets|APDN: Cumulative Company Assets|BLUE - Company Total Assets|immunoprecise.com (IPA) - Aggregate Company Assets|Total Business Assets OMGA|Aggregate Company Assets Singular Genomics Systems Inc|Company Assets Regulus RGLS|Aggregate Company Assets Syros Pharmaceuticals (SYRS)|telesisbio.com - Total Business Assets|TRACON Pharmaceuticals, Inc. - Cumulative Company Assets|Aggregate Asset Value UBX